Catheter Ablation vs Antiarrhythmic Drug Escalation Therapy in Patients With Ventricular Tachycardia
The catheter ablation group experienced a significantly lower rate of the primary outcome compared with the escalated therapy group.
Tachycardia
Oral Progesterone May Effectively Reduce Risk of Drug-Induced QTc Interval Prolongation
Medication-induced QT interval prolongation may be attenuated via oral progesterone in healthy, premenopausal women.
First Leadless Pacemaker Approved by FDA
Less than 7% of patients experienced complications, including extended hospital stays, deep vein thrombosis, pulmonary embolism, heart injury, heart attack, and dislocation.
Amiodarone, Lidocaine Failed to Improve Survival in Out-of-Hospital Cardiac Arrest vs Placebo
Survival for out-of-hospital cardiac arrest to hospital discharge was 24.4% in the amiodarone group, 23.7% in the lidocaine group, and 21% in the placebo group.
Radiofrequency Catheter Ablation Reduces Defibrillator Shocks and Ventricular Tachycardia Recurrence
Radiofrequency catheter ablation provides dramatic short-term and steady long-term ventricular tachycardia nonrecurrence.
Decreased Relative Wall Thickness Associated With Ventricular Arrhythmia in Mild Heart Failure
Cardiac resynchronization therapy with defibrillator therapy was associated with a greater increase in relative wall thickness compared with implantable cardioverter-defibrillator therapy.
Discoloration of Norepinephrine Biartrate Leads to Voluntary Recall
Discoloration of norepinephrine biartrate is indicative of degradation and could lead to decreased effectiveness.
- Loading...
Loading...
Loading... 
Loading...